(-0.08%) 5 304.25 points
(-0.09%) 40 140 points
(-0.05%) 18 465 points
(-0.07%) $83.11
(-0.62%) $1.752
(0.73%) $2 254.80
(0.74%) $25.10
(0.21%) $923.00
(0.02%) $0.927
(0.25%) $10.87
(0.04%) $0.793
(0.02%) $92.59
Live Chart Being Loaded With Signals
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine...
Stats | |
---|---|
Today's Volume | 1.07M |
Average Volume | 1.33M |
Market Cap | 136.09B |
EPS | $0 ( 2024-01-30 ) |
Next earnings date | ( $0 ) 2024-04-29 |
Last Dividend | $0.750 ( 2023-09-28 ) |
Next Dividend | $0 ( N/A ) |
P/E | 43.38 |
ATR14 | $0.151 (0.04%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2024-03-21 | Stiles Spencer S | Buy | 203 | Common Stock |
2024-03-21 | Stiles Spencer S | Sell | 3 796 | Common Stock |
2024-03-21 | Stiles Spencer S | Sell | 203 | Dividend Equivalents |
2024-03-21 | Pierce James Andrew | Buy | 203 | Common Stock |
2024-03-21 | Pierce James Andrew | Sell | 4 412 | Common Stock |
INSIDER POWER |
---|
-59.40 |
Last 100 transactions |
Buy: 383 181 | Sell: 1 508 551 |
Volume Correlation
Stryker Corp Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Stryker Corp Correlation - Currency/Commodity
Stryker Corp Financials
Annual | 2023 |
Revenue: | $20.50B |
Gross Profit: | $13.06B (63.70 %) |
EPS: | $8.34 |
Q4 | 2023 |
Revenue: | $5.82B |
Gross Profit: | $3.70B (63.68 %) |
EPS: | $3.01 |
Q3 | 2023 |
Revenue: | $4.91B |
Gross Profit: | $3.16B (64.33 %) |
EPS: | $1.820 |
Q2 | 2023 |
Revenue: | $5.00B |
Gross Profit: | $3.18B (63.67 %) |
EPS: | $1.950 |
Financial Reports:
No articles found.
Stryker Corp Dividends
(Q3/22) | (Q4/22) | (Q1/23) | (Q2/23) | (Q3/23) | (Q4/23) | (Q1/24) | (Q2/24) | (Q3/24) | (Q4/24) |
$0.695 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0.750 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
$0 (N/A) |
Very Unsafe
High risk of being cut
Unsafe
Heightened risk of being cut
Borderline
Moderate risk of being cut
Safe
Unlikely to be cut
Very Safe
Very unlikely to be cut
First Dividend | $0.00150 | 1991-12-24 |
Last Dividend | $0.750 | 2023-09-28 |
Next Dividend | $0 | N/A |
Payout Date | 2023-10-31 | |
Next Payout Date | N/A | |
# dividends | 75 | -- |
Total Paid Out | $25.16 | -- |
Avg. Dividend % Per Year | 0.67% | -- |
Score | 5.39 | -- |
Div. Sustainability Score | 10.00 | |
Div.Growth Potential Score | 6.07 | |
Div. Directional Score | 9.57 | -- |
Year | Amount | Yield |
---|---|---|
1991 | $0.00150 | 0.08% |
1992 | $0.00100 | 0.02% |
1993 | $0.00213 | 0.04% |
1994 | $0.00225 | 0.06% |
1995 | $0.00275 | 0.06% |
1996 | $0.00625 | 0.10% |
1997 | $0.0275 | 0.37% |
1998 | $0.00750 | 0.08% |
1999 | $0.0325 | 0.24% |
2000 | $0.0400 | 0.23% |
2001 | $0.0500 | 0.21% |
2002 | $0.0600 | 0.21% |
2003 | $0.0700 | 0.21% |
2004 | $0.0900 | 0.22% |
2005 | $0.110 | 0.23% |
2006 | $0.220 | 0.49% |
2007 | $0.330 | 0.60% |
2008 | $0.400 | 0.54% |
2009 | $0.250 | 0.61% |
2010 | $0.630 | 1.21% |
2011 | $0.753 | 1.38% |
2012 | $0.904 | 1.77% |
2013 | $1.100 | 1.97% |
2014 | $1.260 | 1.69% |
2015 | $1.415 | 1.51% |
2016 | $1.565 | 1.74% |
2017 | $1.745 | 1.46% |
2018 | $1.930 | 1.22% |
2019 | $2.14 | 1.38% |
2020 | $2.36 | 1.12% |
2021 | $2.59 | 1.08% |
2022 | $2.84 | 1.06% |
2023 | $2.25 | 0.92% |
2024 | $0 | 0.00% |
The company's strong Dividend Sustainability Score (DSS) indicates its robust capacity to uphold current dividend levels. However, its Dividend Growth Potential Score (DGPS) is only moderate, indicating limited growth potential. In summary, the company provides a promising overall dividend outlook, balancing both sustainability and growth potential.
Symbol | Title | Last dividend | Frequency | Years Dividend | Yearly Dividend | Score |
---|---|---|---|---|---|---|
LOMA | Dividend Knight | 2023-06-30 | Quarterly | 2 | 5.23% | 8.53 |
GOF | Dividend Royal | 2023-11-14 | Monthly | 18 | 8.03% | 8.50 |
SCM | Dividend King | 2023-12-15 | Monthly | 13 | 7.08% | 8.50 |
KIO | Dividend Royal | 2023-12-14 | Monthly | 12 | 7.05% | 8.50 |
SJT | Dividend Royal | 2023-11-29 | Monthly | 39 | 12.52% | 8.50 |
PHK | Dividend Royal | 2023-11-10 | Monthly | 22 | 6.88% | 8.50 |
NCV | Dividend Royal | 2024-02-09 | Monthly | 22 | 7.68% | 8.50 |
JQC | Dividend Royal | 2023-11-14 | Monthly | 22 | 6.56% | 8.50 |
PCF | Dividend King | 2023-12-18 | Monthly | 38 | 7.05% | 8.50 |
PVL | Dividend Royal | 2023-11-15 | Monthly | 14 | 9.37% | 8.50 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
netProfitMarginTTM | 0.154 | 1.500 | 6.91 | 10.00 | [0 - 0.5] |
returnOnAssetsTTM | 0.0793 | 1.200 | 7.36 | 8.83 | [0 - 0.3] |
returnOnEquityTTM | 0.179 | 1.500 | 9.12 | 10.00 | [0.1 - 1] |
payoutRatioTTM | 0.360 | -1.000 | 6.40 | -6.40 | [0 - 1] |
currentRatioTTM | 1.580 | 0.800 | 7.10 | 5.68 | [1 - 3] |
quickRatioTTM | 0.861 | 0.800 | 9.64 | 7.71 | [0.8 - 2.5] |
cashRatioTTM | 0.375 | 1.500 | 9.03 | 10.00 | [0.2 - 2] |
debtRatioTTM | 0.326 | -1.500 | 4.57 | -6.86 | [0 - 0.6] |
interestCoverageTTM | 69.43 | 1.000 | 10.00 | 10.00 | [3 - 30] |
operatingCashFlowPerShareTTM | 9.77 | 2.00 | 6.74 | 10.00 | [0 - 30] |
freeCashFlowPerShareTTM | 8.25 | 2.00 | 5.87 | 10.00 | [0 - 20] |
debtEquityRatioTTM | 0.699 | -1.500 | 7.20 | -10.00 | [0 - 2.5] |
grossProfitMarginTTM | 0.637 | 1.000 | 2.72 | 2.72 | [0.2 - 0.8] |
operatingProfitMarginTTM | 0.190 | 1.000 | 8.21 | 8.21 | [0.1 - 0.6] |
cashFlowToDebtRatioTTM | 0.286 | 1.000 | 9.52 | 9.52 | [0.2 - 2] |
assetTurnoverTTM | 0.514 | 0.800 | 9.91 | 7.93 | [0.5 - 2] |
Total Score | 13.07 |
Ratio | Actual Value | Weight | Normalized Value | Score | Range |
---|---|---|---|---|---|
peRatioTTM | 42.97 | 1.000 | 5.76 | 0 | [1 - 100] |
returnOnEquityTTM | 0.179 | 2.50 | 9.44 | 10.00 | [0.1 - 1.5] |
freeCashFlowPerShareTTM | 8.25 | 2.00 | 7.25 | 10.00 | [0 - 30] |
dividendYielPercentageTTM | 1.076 | 1.500 | 10.00 | 0 | [0 - 0.4] |
operatingCashFlowPerShareTTM | 9.77 | 2.00 | 6.74 | 10.00 | [0 - 30] |
payoutRatioTTM | 0.360 | 1.500 | 6.40 | -6.40 | [0 - 1] |
pegRatioTTM | 0.238 | 1.500 | -1.750 | 0 | [0.5 - 2] |
operatingCashFlowSalesRatioTTM | 0.181 | 1.000 | 7.97 | 0 | [0.1 - 0.5] |
Total Score | 6.07 |
Stryker Corp
Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. This segment also offers spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The MedSurg and Neurotechnology segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical device products that are used in various medical specialties. This segment also provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke; and craniomaxillofacial implant products, including cranial, maxillofacial, and chest wall devices, as well as dural substitutes and sealants. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators